tiprankstipranks
Trending News
More News >

China Literature Expects 2024 Net Loss Due to Goodwill Impairment

Story Highlights
  • China Literature anticipates a net loss due to a goodwill impairment from a past acquisition.
  • The company plans to focus on high-quality content, aiming for long-term market strength.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
China Literature Expects 2024 Net Loss Due to Goodwill Impairment

Confident Investing Starts Here:

China Literature ( (HK:0772) ) has issued an announcement.

China Literature Limited has issued a profit warning, anticipating a net loss of RMB150 million to RMB250 million for the 2024 financial year, primarily due to a non-cash impairment of goodwill from its 2018 acquisition of New Classics Media Holdings Limited. Despite the expected loss, the company plans to focus on developing top-tier film and drama content, which may lead to higher production costs and extended project timelines. However, this strategic shift is expected to strengthen its market position and create long-term value for its intellectual property business.

More about China Literature

China Literature Limited is a company involved in the creation and distribution of online literature and related media content. It focuses on producing high-quality film and drama series content, aiming to establish a strong position in the high-end production industry.

YTD Price Performance: 16.43%

Average Trading Volume: 375

Technical Sentiment Consensus Rating: Sell

Current Market Cap: $4.17B

Find detailed analytics on 0772 stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App